Dr. Reddy's recalls muscle relaxer; GE builds vaccine plant in Brazil; Impax sued over manufacturing issues;

> Dr. Reddy's Laboratories has initiated recall of its tizanidine tablets, used as a muscle relaxer, from the U.S. because of labeling issues. Report

> Vaccine manufacturers will rely on new technology to more quickly produce vaccine to fight the new outbreak of bird flu in China. Story

> GE Healthcare ($GE) has signed a contract to design a manufacturing facility for Bio-Manguinhos/Fiocruz in Brazil that will use iBio's ($IBIO) plant-based manufacturing platform. Release

> A securities lawsuit has been filed against Impax Laboratories ($IPXL) contending that executives misled investors about what impact problems at its Hayward, CA, manufacturing plant would have on the launch of its drug Rytary for Parkinson's disease. Release

> Catalent Pharma Solutions has bought the exclusive license to market Redwood Bioscience's proprietary precision protein-chemical engineering technology for the development of advanced antibody-drug conjugates. Release

And Finally... A maker of oxygen-absorbing canisters for the pharma industry issued a statement to declare loud and clear that it was not its products that led to the recall by Pfizer ($PFE) of 52,000 bottles of its thyroid pill Levoxyl because of a bad odor. Story